Oxymetazoline Levels and Effects while Breastfeeding
Summary of Use during Lactation
Although no information exists on the use of oxymetazoline specifically during breastfeeding, very little should reach the infant through breastmilk because of the local administration and limited absorption into the maternal bloodstream. It is recommended over oral systemic decongestants such as pseudoephedrine during breastfeeding.[1] Topical use on the face is unlikely to present a risk to the nursing infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
1.
Anderson PO. Decongestants and milk production. J Hum Lact 2000;16:294. Letter. PMID: 11155604. [PubMed: 11155604]
Substance Identification
Substance Name
Oxymetazoline
CAS Registry Number
1491-59-4
Drug Class
Breast Feeding
Lactation
Adrenergic alpha-Agonists
Sympathomimetics
Nasal Decongestants
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
